insights_auto
Bakit bumaba ang QURE 3.29%?
Tingnan ang Higit pang Detalyechevron_right
QURE:NASDAQ
Uniqure NV
$21.78
arrow_downward
-3.29%(-0.74) 1D
$21.65
arrow_downward
-0.60% (-0.13)bedtimePagkalipas ng oras ng trabaho
Sarado: Okt 16, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa QURE...
Buksan
$22.50
Mataas
$22.68
Mababa
$21.70
Mkt. cap
1.51B
Avg. na dami
2.89M
Dami
1.29M
Mataas nang 52-wk
$71.50
Mababa nang 52-wk
$8.73
EPS
-$4.05
Beta
1.06
Mga natitirang share
69.37M
Bilang ng mga empleyado
221
Buksan
$22.50
Mataas
$22.68
Mababa
$21.70
Mkt. cap
1.51B
Avg. na dami
2.89M
Dami
1.29M
Mataas nang 52-wk
$71.50
Mababa nang 52-wk
$8.73
EPS
-$4.05
Beta
1.06
Mga natitirang share
69.37M
Bilang ng mga empleyado
221
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
1 araw ang nakalipas
UBS sets USD 48 target for uniQure stock as it trades 1.60 percent lower
Pluang
·
3 araw ang nakalipas
uniQure shares plunge 37% after new trial data shows reduced benefit for Huntington's drug AMT-130
https://www.dars.gov.et/
·
5 araw ang nakalipas
QURE Q2 2026 Earnings: Wider-Than-Expected Loss as Clinical-Stage Spending Weighs on Results - Mid-Term Outlook
Profile
uniQure is a Dutch biopharmaceutical company which makes gene therapies. It has developed several adeno-associated virus gene therapies. Wikipedia
Tungkol sa Uniqure NV